DJIA 17,630.27 189.68 1.09%
NASDAQ 5,089.21 0.00 0.00%
S&P 500 2,093.25 25.61 1.24%
market minute promo

Biogen Idec (NASDAQ: BIIB)



company name or ticker
Company Photos
(Click to zoom)

Gilead Q2 Earnings: KAPOW! BAM! BOOM! (Yes, That Good)

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceu

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases

Is More M&A On The Way For Large-Cap Biotechs?

ISIS Pharmaceuticals: Another Entry Point

Tuesday 7/28 Insider Buying Report: BIIB, MJN

InsiderInsights.com Daily Round Up 7/27/15: Allegheny Technologies, Fibrocell Science, Mead Johnson

InsiderInsights.com Daily Round Up 7/27/15: Allegheny Technologies, Fibrocell Science, Mead Johnson Nutrition, Mobile Mini

Watching Twitter for Moves at Teva and Biogen

3 Big Biotech Buybacks That Investors Should Love

Big biotech companies are flush with cash and are using it to reward shareholders. Here are three companies that are spending big on share buybacks.

5 Things Biogen's Management Wants You to Know

Tecfidera, more Tecfidera, and how to replace Tecfidera growth.

Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash

See More Articles...